Dr. Allison Betof Warner on Outcomes With Anti-PD1 Therapy in Melanoma

June 13, 2019
Allison Betof Warner, MD, PhD
Allison Betof Warner, MD, PhD

Cancer Network spoke with Allison Betof Warner, MD, PhD, of Memorial Sloan Kettering Cancer Center, about long-term outcomes and responses to retreatment in patients with melanoma receiving anti-PD1 therapy.

Cancer Network spoke with Allison Betof Warner, MD, PhD, of Memorial Sloan Kettering Cancer Center, on responders to anti-PD1 therapy, including long-term outcomes and responses to retreatment in patients with melanoma. Warner presented this data (abstract 9513) at ASCO 2019.